Merck strengthens oncology pipeline through strategic partnership with Hengrui Ruchika Sharma31 Oct 2023 2:28 PM ISTGermany: Merck, a science and technology company, has announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. The...
USFDA issues EIR for Ipca Labs SEZ Indore facility Ruchika Sharma31 Oct 2023 1:30 PM ISTMumbai: Ipca Labs has announced that the United States of Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR)...
Bristol Myers Squibb Opdivo in combo with cisplatin based chemotherapy gets EMA validation for Urothelial Carcinoma Ruchika Sharma31 Oct 2023 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its type II variation application for...
Phase III trial of Jemperli plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma31 Oct 2023 11:35 AM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
Intas Pharma to commercialise Serplulimab in India Ruchika Sharma30 Oct 2023 3:29 PM ISTSerplulimab will be commercialised by Intas in India and by its subsidiary, Accord Healthcare Ltd, in Europe.
Sanofi considers listing consumer unit late next year Ruchika Sharma30 Oct 2023 2:30 PM ISTNew Delhi: Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next year, the French drugmaker...
Dr Reddy's Labs gets 10 USFDA observations for Bachupally facility Ruchika Sharma30 Oct 2023 1:30 PM ISTHyderabad: Dr Reddy's Labs has recently announced that the United States Food & Drug Administration (USFDA) has competed an inspection with ten...
Sun Pharma to now offer Desidustat, first oral treatment for CKD-associated anaemia in India under brand Rytstat Ruchika Sharma30 Oct 2023 12:50 PM ISTMumbai: Strengthening its position in the chronic kidney disease space, Sun pharma is now going to offer Desidustat, the first-of-its-kind oral...
SPARC concludes enrolment in global Phase 2 study of Vodobatinib in early Parkinson's disease Ruchika Sharma30 Oct 2023 11:30 AM ISTVodobatinib is a potential first-in-class, highly selective and brain penetrating c-Abl inhibitor.
Strides Pharma Science posts consolidated net loss of Rs 149 crore in Q2 Ruchika Sharma30 Oct 2023 10:00 AM ISTNew Delhi: Strides Pharma Science has reported a consolidated net loss of Rs 149 crore for the second quarter ended September 30, 2023.The drug firm...
Strides to sell manufacturing facility in Singapore for Rs 125 crore Ruchika Sharma29 Oct 2023 4:00 PM IST"Proceeds from the transaction will be utilized for debt reduction," Strides stated.
Exemed Gets CDSCO Panel Nod To study dapagliflozin, Sacubitril, Valsartan as Sodium salt tablet Dr. Divya Colin29 Oct 2023 1:21 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
